Sponsored Links
| Fresenius Medical Care Announces Encouraging Results Of CALMAG Study On Phosphate Binder OsvaRen® At The 2010 EDTA Congress In Munich |
 |
 |
 |
| Events and Conferences - Conferences | |||
|
Based on data from its recently completed CALMAG (CALcium acetate MAGnesium carbonate evaluation) study, Fresenius Medical Care is announcing a demonstration of the effectiveness of its combined phosphate binder OsvaRen® (calcium acetate/magnesium carbonate) in the treatment of hyperphosphatemia in hemodialysis patients... Read more: Conferences News From Medical News Today
|